BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37391712)

  • 21. Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.
    Teng Y; Li T; Yang Z; Su M; Ni J; Wei M; Shi J; Tian J
    Front Neurol; 2021; 12():791014. PubMed ID: 35095736
    [No Abstract]   [Full Text] [Related]  

  • 22. Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
    Casault C; Alikhani K; Pillay N; Koch M
    J Neuroimmunol; 2015 Dec; 289():84-6. PubMed ID: 26616875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
    Li Z; Cui T; Shi W; Wang Q
    Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
    Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
    Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
    Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
    Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review.
    Li X; Yuan J; Liu L; Hu W
    BMC Neurol; 2019 Feb; 19(1):19. PubMed ID: 30732585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
    Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
    Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis.
    Giorelli M; Aniello MS; Altomare S; Leone R; Liuzzi D
    Cureus; 2023 Mar; 15(3):e35882. PubMed ID: 37033571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune encephalitis related to LGI1 antibodies with negative MRI study: Description of two cases.
    Lian X; Zheng K; Chen W; Li D; Xue F; Wang G
    Med Clin (Barc); 2024 Jan; 162(1):35-38. PubMed ID: 37517931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
    Fujita H; Shioda M; Suzuki K
    BMC Neurol; 2022 Apr; 22(1):148. PubMed ID: 35448972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LGI1-negative faciobrachial dystonic-like seizures originating from the insula.
    Patira R; Khatri V; Gutierrez C; Zubkov S
    Epilepsy Behav Case Rep; 2016; 6():33-5. PubMed ID: 27489774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-LGI1 encephalitis with initiating symptom of seizures in children.
    Wang Y; Zhang D; Tong L; Yang L; Yin P; Li J; Lei G; Yang X; Li B
    Front Neurosci; 2023; 17():1151430. PubMed ID: 37179544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature.
    Karvigh SA; Salehizadeh S; Vahabizad F
    J Med Case Rep; 2022 Nov; 16(1):409. PubMed ID: 36348436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faciobrachial motor seizures: A more apt description?
    Muthusamy S; Foroush NC; Seneviratne U
    Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
    Weihua Z; Haitao R; Jie D; Changhong R; Ji Z; Anna Z; Hongzhi G; Xiaotun R
    J Neuroimmunol; 2022 Sep; 370():577918. PubMed ID: 35853356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
    Li Y; Song F; Liu W; Wang Y
    Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
    Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
    BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
    Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
    BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report/Case Series: Rare case of anti-LGI1 limbic encephalitis with rapidly progressive dementia, psychiatric symptoms, and frequently seizures: A case report.
    Wu H; Mei F; Liu L; Zhang L; Hao H; Zhang S
    Medicine (Baltimore); 2021 Jul; 100(29):e26654. PubMed ID: 34398024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.